Author

Marijo Otero‐Lobato

Observed names: M Otero-Lobato, M. Otero-Lobato, Marijo Otero-Lobato, Otero-Lobato, Marijo

Institution: Johnson & Johnson (Netherlands)

Observed institutions: Janssen (Belgium), Janssen (Netherlands), Johnson & Johnson (Netherlands)

ORCID: 0000-0002-6828-1975

Observed ORCID: 0000-0002-6828-1975

OpenAlex ID: A5013255958

Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)—a company experience

2022 · Suzan Esslinger, Linda Quinn, et al. · Journal of Pharmaceutical Health Care and Sciences · 22

Exposure to golimumab during pregnancy: Results from the Company's global safety database

2024 · Marijo Otero‐Lobato, Adesoji Adeyemo, et al. · Pharmacology Research & Perspectives · 8

Post-approval Safety Surveillance Study of Golimumab in the Treatment of Rheumatic Disease Using a United States Healthcare Claims Database

2020 · Najat J. Ziyadeh, Anja Geldhof, et al. · Clinical Drug Investigation · 6

Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019

2024 · Pär Karlsson, Karin Gembert, et al. · Pharmacoepidemiology and Drug Safety · 3

Effectiveness of the golimumab educational program in ensuring healthcare professionals’ awareness of risks described in the European risk management plan

2019 · Lauren Felo, Marijo Otero-Lobato, et al. · Therapeutic Advances in Drug Safety · 3

Colectomy and Neoplasia Outcomes of Patients With Ulcerative Colitis Receiving Golimumab: A Post‐Authorisation Safety Study Using the Spanish ENEIDA Registry

2025 · Eugeni Domènech, Joan Fortuny, et al. · Pharmacoepidemiology and Drug Safety · 1

Sat0117 Trimester Exposure and Pregnancy Outcomes in Women Exposed to Golimumab – Results From the Company Pharmacovigilance Database

2020 · M. Otero-Lobato, S. Esslinger, et al. · Annals of the Rheumatic Diseases · 1

P599 Trimester exposure and pregnancy outcomes in women exposed to golimumab: Results from the company pharmacovigilance database

2020 · S Esslinger, M Otero-Lobato, et al. · Journal of Crohn s and Colitis · 1

Report describing toolbox of methodologies and approaches for WPs to engage stakeholders regarding new evidence on the use of medicines in pregnancy and lactation (D6.3)

2021 · Huys, Isabelle, van Poelgeest-Pomfret, Mary Lynne, et al. · Zenodo (CERN European Organization for Nuclear Research)

Works count: 9

Citation count: 45

H-index: 3

I10-index: 1